• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种糖脂结合蛋白(GM2激活剂)基因的突变,可导致GM2神经节苷脂贮积症AB型。

A mutation in the gene of a glycolipid-binding protein (GM2 activator) that causes GM2-gangliosidosis variant AB.

作者信息

Schröder M, Schnabel D, Suzuki K, Sandhoff K

机构信息

Institut für Organische Chemie und Biochemie Bonn, Germany.

出版信息

FEBS Lett. 1991 Sep 23;290(1-2):1-3. doi: 10.1016/0014-5793(91)81211-p.

DOI:10.1016/0014-5793(91)81211-p
PMID:1915858
Abstract

GM2-gangliosidoses are neurological disorders caused by a genetic deficiency of either the beta-hexosaminidase A or the GM2 activator, a glycolipid binding protein. In a patient with an immunologically proven GM2 activator protein deficiency, A T412----C transition (counted from A of the initiation codon) was found in the coding sequence, which results in the substitution of Arg for the normal Cys107 in the mature GM2 activator protein. The remainder of the coding sequence remained entirely normal.

摘要

GM2神经节苷脂沉积症是一种神经疾病,由β-己糖胺酶A或GM2激活蛋白(一种糖脂结合蛋白)的基因缺陷引起。在一名经免疫证实存在GM2激活蛋白缺陷的患者中,在编码序列中发现了一个T412→C转换(从起始密码子的A开始计数),这导致成熟GM2激活蛋白中正常的半胱氨酸107被精氨酸取代。编码序列的其余部分完全正常。

相似文献

1
A mutation in the gene of a glycolipid-binding protein (GM2 activator) that causes GM2-gangliosidosis variant AB.一种糖脂结合蛋白(GM2激活剂)基因的突变,可导致GM2神经节苷脂贮积症AB型。
FEBS Lett. 1991 Sep 23;290(1-2):1-3. doi: 10.1016/0014-5793(91)81211-p.
2
A Cys138-to-Arg substitution in the GM2 activator protein is associated with the AB variant form of GM2 gangliosidosis.GM2激活蛋白中第138位半胱氨酸到精氨酸的替换与GM2神经节苷脂病的AB变异型有关。
Am J Hum Genet. 1992 May;50(5):1046-52.
3
Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A.与GM2神经节苷脂贮积症AB变异型相关的Cys138Arg替代的生化特征:β-己糖胺酶A识别GM2激活剂/GM2神经节苷脂复合物需要Cys138的证据。
Biochemistry. 1998 Jan 20;37(3):814-21. doi: 10.1021/bi971211s.
4
Molecular analysis of a GM2-activator deficiency in two patients with GM2-gangliosidosis AB variant.两名GM2神经节苷脂贮积症AB变异型患者GM2激活剂缺乏的分子分析
Am J Hum Genet. 1996 Nov;59(5):1048-56.
5
Molecular genetics of GM2-gangliosidosis AB variant: a novel mutation and expression in BHK cells.
Hum Genet. 1993 Nov;92(5):437-40. doi: 10.1007/BF00216446.
6
Biochemical consequences of mutations causing the GM2 gangliosidoses.导致GM2神经节苷脂贮积症的突变的生化后果。
Biochim Biophys Acta. 1999 Oct 8;1455(2-3):105-38. doi: 10.1016/s0925-4439(99)00074-5.
7
[GM2 activator protein deficiency (AB variant form of GM2 gangliosidosis)].[GM2激活蛋白缺乏症(GM2神经节苷脂贮积症的AB变异型)]
Ryoikibetsu Shokogun Shirizu. 1998(19 Pt 2):411-3.
8
AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.婴儿型GM2神经节苷脂沉积症AB变异型:刺激己糖胺酶A催化神经节苷脂GM2和糖脂GA2降解所需因子的缺乏。
Proc Natl Acad Sci U S A. 1978 Aug;75(8):3979-83. doi: 10.1073/pnas.75.8.3979.
9
Isolation of a cDNA encoding the human GM2 activator protein.编码人GM2激活蛋白的cDNA的分离
FEBS Lett. 1989 Jul 17;251(1-2):197-200. doi: 10.1016/0014-5793(89)81454-1.
10
Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.通过基于荧光共振能量转移(FRET)的检测系统合成新型NBD-GM1和NBD-GM2用于GM2激活蛋白的转移活性研究
Glycobiology. 2005 Dec;15(12):1302-11. doi: 10.1093/glycob/cwj018. Epub 2005 Aug 3.

引用本文的文献

1
GM2 activator deficiency: An ultra-rare disorder with a new case and review of 22 published cases.GM2激活剂缺乏症:一种极为罕见的疾病,新增一例病例并对22例已发表病例进行综述。
Mol Genet Metab Rep. 2025 Apr 29;43:101225. doi: 10.1016/j.ymgmr.2025.101225. eCollection 2025 Jun.
2
The Biology of Lysosomes: From Order to Disorder.溶酶体生物学:从有序到无序
Biomedicines. 2023 Jan 14;11(1):213. doi: 10.3390/biomedicines11010213.
3
The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.GM2神经节苷脂沉积症:揭开发病机制与治疗的奥秘
Neurosci Lett. 2021 Nov 1;764:136195. doi: 10.1016/j.neulet.2021.136195. Epub 2021 Aug 25.
4
Plasma Biomarkers of Reticular Pseudodrusen and the Risk of Progression to Advanced Age-Related Macular Degeneration.网状假性玻璃膜疣的血浆生物标志物与进展为晚期年龄相关性黄斑变性的风险
Transl Vis Sci Technol. 2020 Sep 11;9(10):12. doi: 10.1167/tvst.9.10.12. eCollection 2020 Sep.
5
Membrane lipids and their degradation compounds control GM2 catabolism at intralysosomal luminal vesicles.膜脂及其降解产物控制溶酶体腔内囊泡中的 GM2 分解代谢。
J Lipid Res. 2019 Jun;60(6):1099-1111. doi: 10.1194/jlr.M092551. Epub 2019 Apr 15.
6
Atypical juvenile presentation of G gangliosidosis AB in a patient compound-heterozygote for c.259G > T and c.164C > T mutations in the gene.一名在该基因中存在c.259G>T和c.164C>T突变的复合杂合子患者出现非典型青少年型G神经节苷脂贮积症AB型。
Mol Genet Metab Rep. 2017 Apr 7;11:24-29. doi: 10.1016/j.ymgmr.2017.01.017. eCollection 2017 Jun.
7
GM2 gangliosidosis AB variant: novel mutation from India - a case report with a review.GM2神经节苷脂沉积症AB变异型:来自印度的新突变——病例报告及文献复习
BMC Pediatr. 2016 Jul 11;16:88. doi: 10.1186/s12887-016-0626-6.
8
Mutation in GM2A Leads to a Progressive Chorea-dementia Syndrome.GM2A基因突变导致进行性舞蹈病-痴呆综合征。
Tremor Other Hyperkinet Mov (N Y). 2015 Jul 9;5:306. doi: 10.7916/D8D21WQ0. eCollection 2015.
9
GM2-Gangliosidosis, AB Variant: Clinical, Ophthalmological, MRI, and Molecular Findings.GM2神经节苷脂沉积症,AB变异型:临床、眼科、磁共振成像及分子学研究结果
JIMD Rep. 2016;25:83-86. doi: 10.1007/8904_2015_469. Epub 2015 Jun 17.
10
Characterizing solution surface loop conformational flexibility of the GM2 activator protein.表征GM2激活蛋白的溶液表面环构象灵活性。
J Phys Chem B. 2014 Sep 11;118(36):10607-17. doi: 10.1021/jp505938t. Epub 2014 Aug 26.